Tirzepatide weight management program in Delray Beach, South FL. Allenby Dermatology
Medically supervised dual GIP/GLP‑1 therapy with personalized monitoring and lifestyle support. Schedule a consultation. Allenby Dermatology
About Tirzepatide®:
Tirzepatide is a prescription dual GIP and GLP‑1 receptor agonist used to help manage weight and improve metabolic health in adults with overweight or obesity when combined with diet and lifestyle changes
How it works:
By activating both GIP and GLP‑1 pathways, tirzepatide can reduce appetite, increase feelings of fullness, slow stomach emptying, and modulate glucose metabolism, which together may promote gradual, clinically meaningful weight loss.
Why choose Tirzepatide?
Greater average weight loss:
Large clinical trials have shown substantial average weight reductions compared with placebo and some older therapies when combined with diet and exercise.
FDA‑cleared technology:
Clinically validated for the treatment of excessive underarm sweating with established safety and effectiveness data.
Dual mechanism:
Targets both GIP and GLP‑1 receptors to enhance appetite control, satiety, and metabolic effects.
Predictable titration:
Gradual dose escalation is used to improve tolerability and support adherence.
Medically supervised care:
Dosing, safety monitoring, and coordination with existing medications are managed by a prescribing clinician.
Integrated approach:
Combined with nutrition and behavior strategies to help support more durable results.
Potential metabolic benefits:
May improve glycemic control, insulin sensitivity, and other cardiometabolic markers in many patients.
Request Information or Consultation
Request a Consultation
"(Required)" indicates required fields
What to Expect With Your Tirzepatide Treatment
Your first visit includes a thorough medical evaluation, review of current medications and medical history, baseline weight and vital signs, and lab testing when indicated. Together you and your provider discuss realistic goals, determine candidacy, and outline a personalized titration and monitoring plan.
Tirzepatide is administered as a once‑weekly subcutaneous injection using a stepwise titration schedule to reach a therapeutic dose while managing side effects. Follow‑up visits or telehealth check‑ins are scheduled to monitor weight trends, tolerability, and any necessary lab work or medication adjustments.
- Initiation and Titration: Gradual dose increases over several weeks to help optimize tolerance and response.
- Early Effects: Many patients notice reduced appetite and smaller portion sizes within about 2 to 4 weeks.
- Weight Change: Measurable weight loss commonly appears within the first 1 to 3 months, with continued change over 3 to 6 months and beyond with ongoing therapy.
- Maintenance: Continuing medication and lifestyle measures may be recommended to help maintain results; stopping treatment often leads to partial weight regain over time.
There is no procedural downtime with Tirzepatide injections. Common short‑term effects include nausea, early fullness, constipation, diarrhea, or mild abdominal discomfort, which often improve over time with titration, dietary adjustments, and supportive measures.
Tirzepatide is prescribed and monitored by a physician; contraindications, medication interactions, and potential risks are reviewed during your consultation. It is not appropriate during pregnancy and should be avoided in people with a personal or family history of medullary thyroid carcinoma or MEN2; rare but serious events such as pancreatitis or gallbladder disease require prompt medical evaluation if symptoms occur.
Commonly Asked Questions
Explore Treatments
Botox®
The Gold Standard in Wrinkle Relaxation
Injectable Fillers
Restore volume and sculpt with natural precision and artistry.
CoolSculpting Elite
FDA-cleared non-invasive body contouring with lasting, natural results.
Laser Skin Rejuvenation
Reveal smoother, more radiant skin with advanced laser technology.
